A033270 Stock Overview
Engages in the manufacture and sale of pharmaceutical products in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 1/6 |
Korea United Pharm Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩19,390.00 |
| 52 Week High | ₩28,900.00 |
| 52 Week Low | ₩18,180.00 |
| Beta | 0 |
| 11 Month Change | -6.33% |
| 3 Month Change | -16.06% |
| 1 Year Change | -22.90% |
| 33 Year Change | -59.52% |
| 5 Year Change | 3.97% |
| Change since IPO | 577.32% |
Recent News & Updates
Recent updates
Shareholder Returns
| A033270 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 4.4% | -3.1% | 2.9% |
| 1Y | -22.9% | 4.8% | -2.8% |
Return vs Industry: A033270 underperformed the KR Pharmaceuticals industry which returned 4.8% over the past year.
Return vs Market: A033270 underperformed the KR Market which returned -2.8% over the past year.
Price Volatility
| A033270 volatility | |
|---|---|
| A033270 Average Weekly Movement | 3.5% |
| Pharmaceuticals Industry Average Movement | 5.2% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in KR Market | 11.6% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A033270 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A033270's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | n/a | Duk-Young Kang | www.kup.co.kr |
Korea United Pharm Inc. engages in the manufacture and sale of pharmaceutical products in South Korea. It offers products in the areas of respiratory system, musculo-skeletal system, gastro-intestinal tract system, cardiovascular system, anti-cancer, anti-infectives, allergy, immune system, central nervous system, and other diseases, as well OTC drugs. The company also exports its products to approximately 40 countries.
Korea United Pharm Inc. Fundamentals Summary
| A033270 fundamental statistics | |
|---|---|
| Market cap | ₩279.51b |
| Earnings (TTM) | ₩20.02b |
| Revenue (TTM) | ₩161.44b |
0.0x
P/E Ratio0.0x
P/S RatioIs A033270 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A033270 income statement (TTM) | |
|---|---|
| Revenue | ₩161.44b |
| Cost of Revenue | ₩76.64b |
| Gross Profit | ₩84.80b |
| Other Expenses | ₩64.78b |
| Earnings | ₩20.02b |
Last Reported Earnings
Sep 30, 2015
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A033270 perform over the long term?
See historical performance and comparisonDividends
2.2%
Current Dividend Yieldn/a
Payout RatioDoes A033270 pay a reliable dividends?
See A033270 dividend history and benchmarks| Korea United Pharm dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Apr 11 2025 |
| Days until Ex dividend | 32 days |
| Days until Dividend pay date | 137 days |
Does A033270 pay a reliable dividends?
See A033270 dividend history and benchmarks